Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

36 evidence items · page 1 / 2

1.75 %The prevalence of HCV was 1.75% in HIV-negative pregnant women attending Saint Camille medical centre in Ouagadougou.

Gabonhépatite C · VIH/sidapublished 2011Tropical medicine & international health : TM & IHeurope_pmcdocument of 4 observations

91.3 %At S/CO threshold of 1.7, the specificity of ELISA for identifying active HCV infection was 91.3%.

Gabonhépatite Cobserved 03/2010 to 01/2013published 2015PloS onePubMeddocument of 9 observations

63 casesAmong HCV-seropositive sera, 63 were negative for HCV RNA (resolved infection).

Gabonhépatite Cpublished 2018Journal of virological methodsPubMeddocument of 5 observations

6.7 %The prevalence of replicative HCV infection was 6.7% of the total population.

Gabonhépatite C · VIH/sidapublished 2017Medecine et sante tropicalesPubMeddocument of 8 observations

57 %The percentage of HCV viremic patients among people living with HIV/AIDS in Gabon was 57% (8/14), representing 1.6% of the total population studied.

Gabonhépatite Cobserved November 2015 to April 2016published 2018PloS onePubMeddocument of 4 observations

20.4 %The seroprevalence of hepatitis C virus in Ogooué-Lolo province was 20.4%.

Gabonhépatite Cpublished 2012PLoS ONEOpenAlexdocument of 7 observationsDOI 10.1371/journal.pone.0042002

The burden of HIV, HBV, and HCV infections remains disproportionately high in sub-Saharan Africa.

Gabonhépatite B · hépatite C · VIH/sidapublished 2021PloS onePubMeddocument of 9 observations

6.2 %The overall seroprevalence of hepatitis C virus (HCV) was 6.2% among blood donors in Koula-Moutou, Southeast Gabon from 2012 to 2017.

Gabonhépatite Cobserved 2012 to 2017published 2018The Pan African medical journaleurope_pmcdocument of 7 observations

87.2 %HCV core Ag was quantified in 34 out of 39 (87.2%) samples that tested positive for HCV RNA.

Gabonhépatite Cobserved 03/2010 to 01/2013published 2015PloS onePubMeddocument of 9 observations

2.38 %The prevalence of HCV was 2.38% in HIV-positive pregnant women attending Saint Camille medical centre in Ouagadougou.

Gabonhépatite C · VIH/sidapublished 2011Tropical medicine & international health : TM & IHeurope_pmcdocument of 4 observations

187 casesAmong HCV-seropositive sera, 187 were positive for HCV RNA (chronic infection), whereas 63 were negative (resolved infection).

Gabonhépatite Cpublished 2018Journal of virological methodsPubMeddocument of 5 observations

2.9 %HCV seroprevalence among people living with HIV/AIDS in Gabon was 2.9% (14/491) between November 2015 and April 2016.

Gabonhépatite Cobserved November 2015 to April 2016published 2018PloS onePubMeddocument of 4 observations

57.3 %Subtype 4e accounted for 57.3% of hepatitis C virus genotype 4 strains in Gabon.

Gabonhépatite Cpublished 2012PLoS ONEOpenAlexdocument of 7 observationsDOI 10.1371/journal.pone.0042002

0.004 p-valueHGV prevalence was significantly higher in blood donors with hepatitis B antigens compared to donors negative for HCV and no hepatitis B antigens (p=0.004).

Gabonhépatite B · hépatite C · Hepatitis G (HGV)published 2013Mediterranean journal of hematology and infectious diseaseseurope_pmcdocument of 5 observationsDOI 10.4084/mjhid.2013.053

11.2 %The seroprevalence of hepatitis C virus in the Gabonese general population was 11.2%.

Gabonhépatite Cpublished 2012PLoS ONEOpenAlexdocument of 7 observationsDOI 10.1371/journal.pone.0042002

3.5 %Among 57 HCV-seropositive patients with available INNO-LIA results, resolved HCV infection was found in two (3.5%).

Gabonhépatite Cobserved 03/2010 to 01/2013published 2015PloS onePubMeddocument of 9 observations

1.6 %HCV seroprevalence among people living with HIV/AIDS in Gabon was 1.6% of the total population studied between November 2015 and April 2016.

Gabonhépatite Cobserved November 2015 to April 2016published 2018PloS onePubMeddocument of 4 observations

2.14 %The prevalence of hepatitis C virus (HCV) was 2.14% in the screened pregnant women attending Saint Camille medical centre in Ouagadougou.

Gabonhépatite Cpublished 2011Tropical medicine & international health : TM & IHeurope_pmcdocument of 4 observations

15.8 %Among 57 HCV-seropositive patients with available INNO-LIA results, possible acute HCV infections were found in nine (15.8%).

Gabonhépatite Cobserved 03/2010 to 01/2013published 2015PloS onePubMeddocument of 9 observations

4 %The combined prevalence of HCV among blood donors in Gabon was 4.0%.

Gabonhépatite Cpublished 2024PloS onePubMeddocument of 5 observations

5.7 %5.7% of hepatitis C virus strains identified in Gabon were genotype 1.

Gabonhépatite Cpublished 2012PLoS ONEOpenAlexdocument of 7 observationsDOI 10.1371/journal.pone.0042002

Lower sensitivity was observed only in individuals who had cleared their HCV infection (presence of HCV-specific Ab in absence of HCV RNA).

Gabonhépatite Cpublished 2018Journal of virological methodsPubMeddocument of 5 observations

7.3 %HCV seroprevalence rate was 7.3% (56/762) among 762 Gabonese HIV-positive adult patients.

Gabonhépatite Cobserved 03/2010 to 01/2013published 2015PloS onePubMeddocument of 9 observations

2.2 %2.2% of hepatitis C virus strains identified in Gabon were genotype 2.

Gabonhépatite Cpublished 2012PLoS ONEOpenAlexdocument of 7 observationsDOI 10.1371/journal.pone.0042002

34 %ELISA detected HCV in 34% of samples, compared to 3% by multiplex PCR.

Gabonhépatite Cpublished 2016The Pan African medical journaleurope_pmcdocument of 4 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.